Medicus Pharma (MDCX) Cash from Operations Growth (1y) (2025)

Medicus Pharma (MDCX) Cash from Operations Growth (1y) (2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Ops. Growth (1y) (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	122.18%
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-33.32%
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	63.07%
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-11.73%
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	75.53%
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	332.04%
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	243.47%
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Medicus Pharma	14.88 Mn	-298,205.43	-	-

Download Data